Company Description

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States.

It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.

GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GlucoTrack, Inc.

Country	Israel
Founded	2001
Industry	Medical Instruments & Supplies
Sector	Healthcare
Employees	6
CEO	Paul V. Goode Ph.D.

Contact Details

Address: 301 Rt 17 North, Suite 800 Rutherford, New Jersey 07070 United States
Phone	972 (8) 675-7878
Website	glucotrack.com

Stock Details

Ticker Symbol	GCTK
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001506983
CUSIP Number	45824Q507
ISIN Number	US45824Q5071
Employer ID	98-0668934
SIC Code	3841

Key Executives

Name	Position
Paul V. Goode Ph.D.	Chief Executive Officer
Mark Tapsak Ph.D.	Vice President of Technology
Drinda Benjamin	Vice President of Marketing
James P. Thrower Ph.D.	Vice President of Engineering
Avner Gal MBA, MSc.EE	Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA	Co-Founder
James S. Cardwell	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Jul 8, 2024	8-K	Current Report
Jul 1, 2024	8-K	Current Report
Jun 20, 2024	8-K	Current Report
Jun 13, 2024	8-K	Current Report
May 24, 2024	8-K	Current Report
May 20, 2024	8-K	Current Report
May 16, 2024	8-K	Current Report
May 15, 2024	8-K	Current Report
May 15, 2024	10-Q	Quarterly Report
May 8, 2024	D	Notice of Exempt Offering of Securities

View All SEC Filings